Embryonic Dopamine Cell Implants for Parkinson's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 1995

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Parkinson Disease
Interventions
PROCEDURE

embryonic dopamine cell implant surgery

Half of the participants received the cell implant surgery, while the other half received the placebo. After the double-blind phase of the study, patients in the placebo group had the option of receiving tissue implants. Fourteen of these patients eventually had transplants.

PROCEDURE

placebo

sham surgery

Trial Locations (3)

10032

The Movement Disorder Center, Columbia-Presbyterian Hospital, New York

11030

North Shore University Hospital, Manhasset

80262

University Hospital, the University of Colorado Health Sciences Center, Denver

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT00038116 - Embryonic Dopamine Cell Implants for Parkinson's Disease | Biotech Hunter | Biotech Hunter